News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Local

Local Expert Favors Net Neutrality

Internet

UIS expert says those without "deep pockets" will have equal access to internet.

in Local

Rauner Holding Fast to Reallocation to Get Through Rest of the Fiscal Year

rauner

The Governor holds General Assembly responsible for budget shortfalls.

in Local

Winter Weather Advisory Effective 6PM Saturday – 6PM Sunday

snowplow

4 - 6 inches of snow expected in the area; snow emergency in effect at 7pm tonight in Springfield.

in Local

Snow Emergency Declared in Springfield; Salt Supplies Plentiful

snowplow

The City of Springfield has declared another snow emergency -- it's in effect from 7:00 Saturday night through 7:00 Monday night.

in Local

Quinn’s Back, Suggests Voters Have “Buyer’s Remorse” with Rauner

pat-quinn

Former Gov. Pat Quinn thinks Illinois may be feeling buyer’s remorse after hearing Gov. Bruce Rauner’s budget plan.